Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with ... Jun 18
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in ... Dec 18
The nasal spray vaccination could generate double protection for vaccine recipients - Influenza and the novel Coronavirus ... Sep 11
Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation ... May 21
Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma ... Feb 28
-Advertisements-
.jpeg)
Friday, April 11, 2025
.jpg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpeg)
.jpeg)
.jpeg)